The Challenges Ahead With Monoclonal Antibodies: From Authorization to Access.

Goldstein, Robert H; Walensky, Rochelle P

Goldstein, Robert H; Walensky, Rochelle P.

Goldstein RH; Division of Infectious Diseases and Division of General Internal Medicine, Department of Medicine, Massachusetts General Hospital, Boston.
Walensky RP; Harvard Medical School, Boston, Massachusetts.

JAMA ; 324(21): 2151-2152, 2020 Dec 01.

Article in English | MEDLINE | ID: covidwho-985856

Subject(s)

Adenosine Monophosphate/analogs & derivatives; Alanine/analogs & derivatives; Antibodies, Monoclonal/therapeutic use; Antiviral Agents/therapeutic use; COVID-19 Drug Treatment; Drug Approval; Adenosine Monophosphate/therapeutic use; Alanine/therapeutic use; Antibodies, Monoclonal/economics; COVID-19/epidemiology; Humans; Pandemics; United States/epidemiology

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / Adenosine Monophosphate / Drug Approval / Alanine / COVID-19 Drug Treatment / Antibodies, Monoclonal Type of study: Observational study Limits: Humans Country/Region as subject: North America Language: English Journal: JAMA Year: 2020 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google